gemcitabine,cisplatin,bevacizumab,carboplatin,paclitaxel,pemetrexed,pembrolizumab,durvalumab,olaparib
astrazeneca,merck,roche
['keynote 671', 'keynote,671', 'keynote 826', 'duo-o']
listening to "day 2 round up asco 2023 (keynote 826, keynote 671, duo-o)" at 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨